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Background: Short sleep duration, recognized as a public health epidemic, is associated with 
adverse health conditions, yet little is known about the association between sleep and bone 
health. We tested the associations of usual sleep behavior and bone mineral density (BMD) and 
osteoporosis. Methods: In a sample of 11,084 postmenopausal women from the Women’s 
Health Initiative (WHI; mean age 63.3, SD=7.4)), we performed a cross-sectional study of the 
association of self-reported usual hours of sleep and sleep quality (WHI Insomnia Rating Score) 
with whole body, total hip, femoral neck, and spine BMD using linear regression models. We 
also studied the association of sleep duration and quality with DXA-defined low bone mass (T-
score <-2.5 to <-1) and osteoporosis (T-score ≤-2.5) using multinomial regression models. We 
adjusted for age, DXA machine, race, menopausal symptoms, education, smoking, physical 
activity, body mass index, alcohol use, physical function, and sleep medication use. Results: In 
adjusted linear regression models, women who reported sleeping 5 hours or less per night had 
on average 0.012-0.018 g/cm2 significantly lower BMD at all four sites compared to women who 
reported sleeping 7 hours per night (reference). In adjusted multinomial models, women 
reporting 5 hours or less per night had higher odds of low bone mass and osteoporosis of the 
hip, OR (95% CI): 1.22 (1.03, 1.45) and 1.63 (1.15, 2.31), respectively. We observed a similar 
pattern for spine BMD, where women with 5 hours or less per night had higher odds of 
osteoporosis; adjusted OR (95% CI): 1.28 (1.02, 1.60). Associations of sleep quality and DXA 
BMD failed to reach statistical significance. Conclusions: Short sleep duration was associated 
with lower BMD and higher risk of osteoporosis. Longitudinal studies are needed to confirm the 
cross-sectional effects of sleep duration on bone health and explore associated mechanisms.   








Sleep is a fundamental biological process that plays a key role in a variety of metabolic 
and endocrine functions(1). Poor sleep is linked to a broad range of adverse health conditions 
including obesity(2), diabetes, hypertension, cardiovascular disease(3) and mortality(4).   
 Low bone density and osteoporotic fractures are common manifestations of aging, and 
associated with both greater risks of morbidity and mortality. Approximately one in three women 
age 50 or older will experience a fracture in her lifetime(5). To our knowledge, there are few large 
studies on the association between sleep health and bone health, including measurements of 
bone mineral density and osteoporosis risk. Since aging is associated with changes in bone 
resorption and bone formation(6), it is prudent to conduct larger epidemiologic studies in 
postmenopausal women who are at highest fracture risk. 
Here, we build on our prior work where we identified an association of short, long, and 
disturbed sleep with recurrent falls and fractures(7) to evaluate whether sleep behavior is also 
associated with BMD. The goal of our study was to examine the association of sleep duration 
and quality with bone mineral density (BMD) at multiple body sites and prevalence of 
osteopenia and osteoporosis. We hypothesized that women with short sleep duration, long 
sleep duration, and poor sleep quality have lower BMD and are more likely to have low bone 
mass and osteoporosis.  




Materials and Methods 
Study Population. The WHI enrolled 161,808 postmenopausal women between the ages of 50-
79 years old at baseline at 40 clinical centers for clinical trials and an observational study. Here, 
we focused on the WHI DXA cohort, a group of women for whom dual x-ray absorptiometry 
(DXA) was measured at one of three clinical centers (Pittsburgh, PA, Birmingham, AL, 
Tucson/Phoenix, AZ)(8). Approximately 11,323 women had a complete DXA scan at the WHI 
baseline visit. After excluding 239 women with incomplete sleep data, we had a final sample of 
11,084 women.  
 
DXA measurement. Hip, spine, and whole body DXA scans were performed using the Hologic 
QDR scanners (QDR 2000, 2000+, or 4500W; Hologic, Waltham, MA, USA) by certified and 
trained operators. Scanners were calibrated daily with body mass phantoms according to the 
manufacturer’s protocol. The WHI DXA coordinating center at the University of California at San 
Francisco monitored scans as a part of the WHI DXA Quality Assurance plan. Random samples 
of non-flagged scans as well as checks for outliers were also conducted as a part of the ongoing 
quality assurance program. Specific bone measures of interest include BMD of the total body, 
total hip, femoral neck, and spine (L2-L4), all measured in g/cm2.  Women were further 
classified as having low bone mass (T-score between -2.5 and -1) and osteoporosis (T-score ≤-
2.5) compared to normal (T-score ≥-1). 
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Sleep variables. Sleep behavior was assessed at WHI baseline using self-administered 
questionnaires. The question on sleep duration asked, “About how many hours of sleep did you 
get on a typical night during the past 4 weeks? (≤5 hours, 6 hours, 7 hours, 8 hours, 9 hours, 
and ≥10 hours).” Sleep quality was assessed using the WHI Insomnia Rating Scale (WHIIRS), 
is a composite index of sleep disturbance ranging from 0-20 with higher numbers indicating 
greater insomnia(9). The score is calculated based on responses to five questions as part of a 
self-reported questionnaire focused on the past 4 weeks: “Did you have trouble falling asleep? 
Did you wake up several times at night? Did you wake up earlier than you planned to? Did you 
have trouble getting back to sleep after you woke too early? Overall, how was your typical 
night’s sleep?”(9).  This score was validated in two independent clinical trials and was sensitive 
to detect changes in sleep behavior associated with hormone therapy use(10).  For this analysis, 
the WHIIRS score was analyzed as a continuous variable with values ranging from 0-20 as well 
as using the cutoff of 9 which signifies insomnia.   
 
Statistical Analysis. For this cross-sectional study, we first performed descriptive and bivariate 
analyses to characterize the sample. We used multivariable-adjusted linear regression models 
to examine the associations of usual sleep duration and the WHIIRS with anatomic site-specific 
BMD measures (whole body, total hip, femoral neck, and spine). We classified the DXA 
measurements into T-scores (using the reference database of the Third National Health and 
Nutrition Examination Survey(11) for hip; Hologic reference databases were used for spine and 
whole body), which enabled us to evaluate the associations of sleep with risk of low bone mass 
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(T-score between -2.5 and -1) and osteoporosis (T-score ≤-2.5) compared to normal (T-score >-
1) using multinomial logistic regression.  
Using linear regression and multinomial logistic models, we estimated both crude 
(adjusted for age, scanner, menopausal symptoms, and race) and adjusted models. Race was 
classified into five categories (American Indian/Alaskan Native, Asian or Pacific Islander, Black 
or African American, Hispanic/Latino, White (non-Hispanic), or other). Other covariates that we 
considered were measured via WHI baseline questionnaires and selected a priori based on 
published literature and include education, smoking, physical activity, and body mass index 
(BMI), alcohol use, physical function score, and sleep medication use. Menopausal symptoms 
were classified as none/mild or moderate/severe if women answered “yes” to having hot flashes 
or night sweats in the past 4 weeks. Education was coded as ≤high school, some college or 
vocational training, college graduate or more. Smoking status was categorical and women were 
classified as never, former, or current smokers. Physical activity was represented using MET-
hours/week (<2.5, 2.5-<5, 5-<12, ≥12). BMI in kg/m2 was modeled as a continuous variable. For 
alcohol use, women were classified as non-drinkers, past drinkers, or current drinkers (<1 drink 
per week, ≥1 drinks per week). The physical function score was measured by the 10-item Rand-
36 physical function score(12) and dichotomized as <70, ≥70. Current sleep medication use was 
categorical and either yes or no.  
 We selected 7 hours of sleep per night as the reference group, since this is the amount 
recommended for adults(13). Sleep duration was recoded for the multinomial models where we 
analyzed sleep duration, collapsing 9 and 10 or more hours per night due to low numbers. 
Analyses were completed using SAS version 9.4 (SAS Institute, Cary, NC). 
This article is protected by copyright. All rights reserved.
9 
 
 In a priori power calculations for linear regression, we assumed a mean BMD (femoral 
neck) of 0.72 g/cm2 (SD=0.12), alpha=0.05, and used a two-sided test. We assumed the above 
parameters and an estimated sleep duration SD of 1.36, and found that we could detect a beta 
as small as 0.002. For sleep quality (WHIIRS), we assumed a SD of 4.5 and found that we 
could detect a beta coefficient as small as 0.001.   
 
Results 
With a mean age of 63.3 years (SD=7.4), our postmenopausal sample is 78% non-
Hispanic white. Approximately 10% of our sample reported sleeping five hours or less per night, 
and 4.5% reported sleeping 9 or more hours per night. Approximately 33% of women met the 
threshold for insomnia, defined using the WHI insomnia rating score; see Table 1.  
In covariate-adjusted linear regression models for total hip, femoral neck, spine and 
whole body BMD, women sleeping 5 hours or less per night had BMD values that were 
approximately 0.015, 0.012, 0.018, and 0.018 g/cm2 lower, compared to women who slept 7 
hours per night (reference group; Table 2). The spine and whole body BMD values were also 
lower on average for women who slept 6 hours per night, for a difference of approximately 0.01 
g/cm2 compared to women sleeping 7 hours/night.  
In multinomial logistic models, women sleeping 5 hours or less per night had significantly 
higher odds of low bone mass of the total hip and whole body compared to women sleeping 7 
hours per night; hip and total body ORs were 1.22 and 1.37, respectively; Table 3. Similarly, 
women sleeping 5 hours or less per night had higher odds of osteoporosis of the total hip, spine 
and whole body; ORs were 1.63, 1.28, and 1.94, respectively. Women sleeping 6 hours per 
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night had higher but slightly attenuated odds of spine and whole body osteoporosis (versus 7 
hours per night), with ORs of 1.17 and 1.27, respectively. For femoral neck BMD, we failed to 
observe statistically significant associations with low bone mass or osteoporosis and sleep 
duration.  
With regard to sleep quality and BMD, we found a mild protective effect for women in the 
7-10 WHIIRS category versus the no insomnia group (0-3 score), where women in this category 
had 0.01 g/cm2 higher hip and femoral neck BMD (95% CIhip: 0.001, 0.014, and 95% CIfemoral neck: 
0.001, 0.013) compared to women with no insomnia; however when adjusted for the full set of 
covariates, these associations became non-significant (data not shown).  
In multinomial models, we observed a protective effect of insomnia on both femoral neck 
and spine low bone mass; women in the 7-10 and ≥11 WHI insomnia rating score category were 
less likely to have low bone mass at the femoral neck (crude OR7-10: 0.86, 95% CI: 0.77, 0.97; 
data not shown); however these became non-significant with covariate adjustment. When we 
evaluated risk for low bone mass and osteoporosis according to the insomnia cutoff (WHIIRS <9 
vs ≥9), we observed no statistically significant associations (data not shown).  
 
Discussion 
In the largest study of sleep and BMD to date in a U.S. postmenopausal female sample, 
our findings indicate that short sleep in older adult women is associated with lower BMD at 
multiple body sites, albeit with modest clinical significance. Specifically, women who slept 5 
hours or less had higher odds of low bone mass and osteoporosis of the total hip and whole 
body. The associations we identified are modest in terms of the continuous BMD measures 
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when comparing across the different sleep duration categories. The difference we observed 
between the ≤5 hour per night group compared to the reference group was approximately -
0.012 to -0.017 g/cm2 (approximately 1.7-1.9%), which is roughly equivalent to one year of 
aging(14,15).  
Currently, the scant literature on the association of sleep and bone mineral density is 
limited to small cross-sectional studies, many of which are outside of the U.S. The largest U.S. 
study, The South Dakota Rural Bone Health Study, showed that short sleep (<6.5 hr/night) was 
associated with lower cortical volumetric BMD (vBMD) at the 20% distal radius in a sample of 
348 women(16). These findings of lower BMD with short sleep were supported by a Chinese 
study (n=602 women); women older than 45 who slept ≤6 hours per night (versus 8 hrs/night) 
had lower total and regional BMD(17). The authors observed no significant associations in the 
<45 year old women which is not surprising given that bone loss begins during perimenopause. 
In a more recent study of 512 women aged 45-65 years by Lucassen et al., authors reported a 
smaller and non-significant effect size for sleep duration and hip BMD (beta=-0.004) than we did 
(-0.016 for hip BMD)(18). Our study, which was larger and had better representation of women 
older than 65, may have had more power to detect the association of short sleep and a higher 
prevalence of low BMD. 
Conversely, long sleep has also been associated with lower BMD(19-21). A Korean study 
that included 1274 women over age 60 found a significant trend of lower BMD of the total hip 
and femoral neck with increasing sleep duration(19). The covariate-adjusted betas were -0.007 
and -0.005 for total hip and femoral neck, respectively. In a French sample that included 290 
women, long sleepers (≥8 hrs) were more likely to have osteoporosis at the femoral neck (OR: 
This article is protected by copyright. All rights reserved.
12 
 
6.29, 95% CI: 1.51, 15.92)(21). Two other studies were null for sleep duration and BMD; one in 
Iceland that analyzed vBMD of the femur, and the other was a study of Puerto Rican women 
analyzed total and regional BMD(20). While our current analysis did not show an association 
between long sleeping and BMD, this may due to low power and the fact that few women in our 
sample (<1%) reported sleeping 10 or more hours/night. The negative coefficients we observed 
for the ≥10 hour group was suggestive of lower BMD in that group, similar to our odds ratio 
estimates for osteoporosis, which were suggestive of higher odds.  
Short sleep duration (<6 hrs) was associated with osteoporosis in a sample of women 
aged 50 or older in NHANES(22). Results from a large Japanese study indicate that long sleep 
duration (>8 hrs) is associated with higher risk of osteoporosis(23). Findings from a Chinese 
study suggest that short sleep, long sleep, and daytime napping is associated with higher odds 
of osteoporosis; these findings were limited to postmenopausal women(24).  
The prior literature shows only few studies focused on the association of sleep quality 
and DXA. Lucassen et al. reported an inverse association of the Pittsburgh Sleep Quality Index 
(PSQI) and BMD in a sample of 512 Dutch women, where a one unit higher PSQI score (higher 
values represent poorer sleep quality) was associated with reduced hip and spine BMD of 
approximately 0.003 g/m2. This study also reported that a one unit increase in PSQI was 
associated with higher osteopenia risk (OR: 1.08, 95% CI: 1.00, 1.17). The PSQI includes a 
dimension of sleep duration while our questionnaire does not. Therefore, their significant 
findings may in part be driven by the influence of sleep duration. The protective effect of 
insomnia on femoral neck and spine BMD that we observed for the low bone mass outcome 
may be due to women being out of bed more often. We adjusted for physical activity, however 
This article is protected by copyright. All rights reserved.
13 
 
this does not represent the activity occurring in the early morning hours resulting from lack of 
sleep. This finding may also be due to chance. Studies including objective assessments of sleep 
are needed.  
 This large cohort of postmenopausal women supported the in depth examination of the 
associations of bone health with sleep duration and quality. Our analysis focused on 
postmenopausal women who are at highest risk for low bone mass and osteoporosis. Our 
results were unchanged when we added comorbidities and hormone therapy use to the models 
(data not shown). It is important to consider the possibility of reverse causality on the sleep-
BMD hypothesis, since lower BMD may be associated with factors that influence sleep 
behavior. Here, we focused on the WHI baseline visit, where postmenopausal women were 
generally healthy and free of chronic conditions. Although our analysis is limited by its cross-
sectional nature and self-reported sleep behavior, we found clear evidence to justify further 
investigations of the associations of sleep with bone health and the underlying mechanisms.  
However, since we evaluated multiple DXA sites, we conducted multiple statistical tests and 
some significant findings may be due to chance. Future studies may use more objective 
measures of sleep such as waist-wearing actigraphy device to improve quality of sleep data, 
and should include the additional consideration of bone microarchitecture. While the 
mechanisms for the association of sleep duration and BMD are not known, inadequate sleep 
duration is thought to impact hormone levels, sympathetic activation25,26, inflammatory 
processes27,28, and involve metabolic derangement. In a meta-analysis, short sleep duration 
was associated with higher levels of C-reactive protein, supporting a role of inflammation28. 
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Further support for a biological explanation for sleep and bone associations comes from the 
ability of insufficient sleep to disrupt the circadian rhythm of bone turnover markers6,29,30. 
In sensitivity analyses, we stratified by race in linear regression models given the 
differences in sleep duration; African Americans in our sample had a higher frequency of short 
sleep duration and are known to have higher BMD compared to whites(31). For whites, the sleep-
BMD associations in whites are unchanged. For African Americans, while none of the sleep 
duration-BMD associations reached statistical significance, the coefficients were in a similar 
direction, suggesting that short sleep is associated with lower BMD. It is difficult to discern 
whether the lack of significance is due to low power given the sample size. Nonetheless, it is 
important for future studies to evaluate these associations in larger samples given the higher 
prevalence of short sleep in African Americans(32).  
 In summary, we have provided epidemiologic evidence into sleep as a partially 
modifiable risk factor for BMD that is deserving of further replication and mechanistic studies. 
Prospective studies are needed to evaluate whether sleep duration is associated with BMD loss 
and the short- and long-term effects of unhealthy sleep patterns on bone health. If studies show 
that sleep duration has a causal link with bone density, sleep promotion interventions may serve 





This article is protected by copyright. All rights reserved.
15 
 
The WHI program is funded by the National Heart, Lung, and Blood Institute, National 
Institutes of Health, U.S. Department of Health and Human Services through contracts 
HHSN268201600001C, HHSN268201100046C, HHSN268201100001C, 
HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and 
HHSN271201100004C. 
This manuscript was prepared in collaboration with investigators of the WHI, and has 
been reviewed and/or approved by the Women’s Health Initiative (WHI).  A list of WHI 










1. Van Cauter E, Plat L, Leproult R, Copinschi G. Alterations of circadian rhythmicity and 
sleep in aging: endocrine consequences. Horm Res. 1998;49(3-4):147-152. 
2. Bayon V, Leger D, Gomez-Merino D, Vecchierini MF, Chennaoui M. Sleep debt and 
obesity. Ann Med. 2014;46(5):264-272. 
This article is protected by copyright. All rights reserved.
16 
 
3. Knutson KL. Sleep duration and cardiometabolic risk: a review of the epidemiologic 
evidence. Best Pract Res Cl En. 2010;24(5):731-743. 
4. Lee WJ, Peng LN, Liang CK, Chiou ST, Chen LK. Long sleep duration, independent of 
frailty and chronic inflammation, was associated with higher mortality: A national 
population-based study. Geriatr Gerontol Int. 2017;17(10):1481-1487. 
5. International Osteoporosis Foundation. Bone Care for the Postmenopausal Woman.  
Available at: http://share.iofbonehealth.org/WOD/2013/thematic-report/WOD13-
Report.pdf. Accessed October 4, 2018. 
6. Swanson CM, Kohrt WM, Buxton OM, Everson CA, Wright KP, Jr., Orwoll ES, et al. The 
importance of the circadian system & sleep for bone health. Metabolis. 2018;84:28-43. 
7. Cauley JA, Hovey KM, Stone KL, Andrews CA, Barbour KE, Hale L, et al. 
Characteristics of self-reported sleep and the risk of falls and fractures: The Women's 
Health Initiative (WHI). J Bone Miner Res. 2019;34(3):464-474. 
8. Jackson RD, Wright NC, Beck TJ, Sherrill D, Cauley JA, Lewis CE, et al. Calcium plus 
vitamin D supplementation has limited effects on femoral geometric strength in older 
postmenopausal women: the Women's Health Initiative. Calcified Tissue Int. 
2011;88(3):198-208. 
9. Levine D, Kaplan RM, Kripke DF, Bowen DJ, Naughton MJ, Shumaker SA. Factor 
structure and measurement invariance of the Women's Health Initiative Insomnia Rating 
Scale. Psychol Assessment. 2003;15(2):123-136. 
This article is protected by copyright. All rights reserved.
17 
 
10. Levine D, Dailey ME, Rockhill B, Tipping D, Naughton MJ, Shumaker SA. Validation of 
the Women's Health Initiative Insomnia Rating Scale in a multicenter controlled clinical 
trial. Psychosom Med. 2005;67:98-104. 
11. Looker AC, Johnston CC, Jr., Wahner HW, Dunn WL, Calvo MS, Harris TB, et al. 
Prevalence of low femoral bone density in older U.S. women from NHANES III. J Bone 
Miner Res. 1995;10(5):796-802. 
12. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health 
Econ. 1993;2(3):217-227. 
13. Watson NF, Badr MS, Belenky G, Bliwise DL, Buxton OM, Buysse D, et al. 
Recommended Amount of Sleep for a Healthy Adult: A Joint Consensus Statement of 
the American Academy of Sleep Medicine and Sleep Research Society. Sleep. 
2015;38(6):843-844. 
14. Berger C, Langsetmo L, Joseph L, Hanley DA, Davison KS, Josse R, et al. Change in 
bone mineral density as a function of age in women and men and association with the 
use of antiresorptive agents. CMAJ. 2008;178(13):1660-1668. 
15. Cauley JA, Lui LY, Stone KL, Hillier TA, Zmuda JM, Hochberg M, et al. Longitudinal 
study of changes in hip bone mineral density in Caucasian and African-American 
women. J Am Geriatr Soc. 2005;53(2):183-189. 
16. Specker BL, Binkley T, Vukovich M, Beare T. Volumetric bone mineral density and bone 
size in sleep-deprived individuals. Osteoporosis Int. 2007;18(1):93-99. 
17. Fu X, Zhao X, Lu H, Jiang F, Ma X, Zhu S. Association between sleep duration and bone 
mineral density in Chinese women. Bone. 2011;49(5):1062-1066. 
This article is protected by copyright. All rights reserved.
18 
 
18. Lucassen EA, de Mutsert R, le Cessie S, Appelman-Dijkstra NM, Rosendaal FR, van 
Heemst D, et al. Poor sleep quality and later sleep timing are risk factors for osteopenia 
and sarcopenia in middle-aged men and women: The NEO study. PloS One. 
2017;12(5):e0176685. 
19. Kim N, Choi HR, Kim SW, Kim BS, Won CW, Kim SY. Association between Bone 
Mineral Density and Sleep Duration in the Korean Elderly Population. Korean J Fam 
Med. 2014;35(2):90-97. 
20. Niu J, Sahni S, Liao S, Tucker KL, Dawson-Hughes B, Gao X. Association between 
sleep duration, insomnia symptoms and bone mineral density in older Boston Puerto 
Rican adults. PloS One. 2015;10(7):e0132342. 
21. Saint Martin M, Labeix P, Garet M, Thomas T, Barthelemy JC, Collet P, et al. Does 
Subjective Sleep Affect Bone Mineral Density in Older People with Minimal Health 
Disorders? The PROOF Cohort. J Clin Sleep Med. 2016;12(11):1461-1469. 
22. Cunningham TD, Di Pace BS. Is Self-Reported Sleep Duration Associated with 
Osteoporosis? Data from a 4-Year Aggregated Analysis from the National Health and 
Nutrition Examination Survey. J Am Geriatr Soc. 2015;63(7):1401-1406. 
23. Kobayashi D, Takahashi O, Deshpande GA, Shimbo T, Fukui T. Association between 
osteoporosis and sleep duration in healthy middle-aged and elderly adults: a large-scale, 
cross-sectional study in Japan. Sleep Breath. 2012;16(2):579-583. 
24. Chen G, Chen L, Wen J, Yao J, Li L, Lin L, et al. Associations between sleep duration, 
daytime nap duration, and osteoporosis vary by sex, menopause, and sleep quality. J 
Clin Endocr Metab. 2014;99(8):2869-2877. 
This article is protected by copyright. All rights reserved.
19 
 
25. Swanson CM, Shea SA, Stone KL, Cauley JA, Rosen CJ, Redline S, et al. Obstructive 
sleep apnea and metabolic bone disease: insights into the relationship between bone 
and sleep. J Bone Miner Res. 2015;30(2):199-211. 
26. Kuriyama N, Inaba M, Ozaki E, Yoneda Y, Matsui D, Hashiguchi K, et al. Association 
between loss of bone mass due to short sleep and leptin-sympathetic nervous system 
activity. Arch Gerontol Geriatr. 2017;70:201-208. 
27. Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF, et al. Effect of 
sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am 
Coll Cardiol. 2004;43(4):678-683. 
28. Irwin MR, Olmstead R, Carroll JE. Sleep Disturbance, Sleep Duration, and Inflammation: 
A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep 
Deprivation. Biol Psychiatry. 2016;80(1):40-52. 
29. Qvist P, Christgau S, Pedersen BJ, Schlemmer A, Christiansen C. Circadian variation in 
the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects 
of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting. Bone. 
2002;31(1):57-61. 
30. Redmond J, Fulford AJ, Jarjou L, Zhou B, Prentice A, Schoenmakers I. Diurnal rhythms 
of bone turnover markers in three ethnic groups. J Clin Endocr Metab. 
2016;101(8):3222-3230. 
31. Wagner DR, Heyward VH. Measures of body composition in blacks and whites: a 
comparative review. Am J Clin Nutr. 2000;71(6):1392-1402. 
This article is protected by copyright. All rights reserved.
20 
 
32. Adenekan B, Pandey A, McKenzie S, Zizi F, Casimir GJ, Jean-Louis G. Sleep in 
America: role of racial/ethnic differences. Sleep Med Rev. 2013;17(4):255-262. 
 
This article is protected by copyright. All rights reserved.
21 
 
Table 1. Characteristics in WHI BMD cohort by hours of sleeping per night. N (%) or Mean (SD). 
  Self-reported usual sleep duration 
 Total ≤5 hours 6 7 8 9 ≥10 hours p-value 
 11,084 1,080 3,157 4,025 2,320 405 97  
Age, yr 63.3 (7.4) 63.2 (7.9) 63.2 (7.4) 63.3 (7.3) 63.4 (7.2) 63.9 (7.5) 61.8 (7.4) 0.137 
Race/ethnicity (n=11,066)         
White, non-Hispanic 8,624 (77.9) 689 (63.8) 2,384 (75.6) 3,300 (82.1) 1,897 (82.1) 306 (75.7) 48 (49.5)  
African-American 1,534 (13.9) 287 (26.6) 518 (16.4) 416 (10.3) 228 (9.9) 58 (14.4) 27 (27.8)  
Hispanic/Latino 676 (6.1) 71 (6.6) 192 (6.1) 220 (5.5) 141 (6.1) 31 (7.7) 21 (21.6)  
American Indian or 
Alaskan Native 
139 (1.3) 16 (1.5) 32 (1.0) 56 (1.4) 29 (1.3) 5 (1.2) 1 (1.0) <0.001 
Asian or Pacific Islander 36 (0.3) 8 (0.7) 10 (0.3) 13 (0.3) 5 (0.2) 0 (0.0) 0 (0.0)  
Other 57 (0.5) 9 (0.8) 18 (0.6) 15 (0.4) 11 (0.5) 4 (1.0) 0 (0.0)  
Education (n=11,007)         
≤High school  3,451 (31.4) 420 (39.2) 992 (31.6) 1,168 (29.2) 706 (30.7) 125 (31.2) 40 (42.1) <0.001 
Some college or 
vocational training 
4,173 (37.9) 408 (38.1) 1,200 (38.2) 1,523 (38.1) 856 (37.2) 149 (37.2) 37 (38.9)  
College graduate 3,383 (30.7) 244 (22.8) 947 (30.2) 1,306 (32.7) 741 (32.2) 127 (31.7) 18 (18.9)  
BMI (kg/m2) (n=11,014) 28.2 (5.9) 29.5 (6.5) 28.5 (5.9) 27.7 (5.6) 27.9 (5.7) 28.8 (6.0) 30.0 (6.7) <0.001 
Recreational physical activity (n=9883)  
<2.5 MET hrs/wk 2,919 (29.5) 369 (37.6) 864 (30.5) 959 (26.8) 572 (27.9) 117 (32.5) 38 (44.2) <0.001 
2.5-<5 MET hrs/wk 1,209 (12.2) 149 (15.2) 357 (12.6) 414 (11.6) 245 (12.0) 34 (9.4) 10 (11.6)  
5-<12 MET hrs/wk 2,280 (23.1) 198 (20.2) 668 (23.6) 874 (24.4) 452 (22.1) 76 (21.1) 12 (14.0)  
≥12 MET hrs/wk 3,475 (35.2) 266 (27.1) 942 (33.3) 1,328 (37.1) 780 (38.1) 133 (36.9) 26 (30.2)  
Alcohol intake (n=10,994)         
Non drinker 1,852 (16.8) 234 (21.8) 519 (16.6) 637 (15.9) 384 (16.7) 60 (15.0) 18 (18.9) <0.001 
Past drinker 2,442 (22.2) 287 (26.8) 725 (23.2) 815 (20.4) 479 (20.8) 99 (24.7) 37 (38.9)  
<1 drink per month 1,432 (13.0) 140 (13.1) 412 (13.2) 525 (13.1) 282 (12.3) 65 (16.2) 8 (8.4)  
<1 drink per week 2,139 (19.5) 190 (17.7) 622 (19.9) 813 (20.3) 436 (19.0) 65 (16.2) 13 (13.7)  
1 to <7 drinks per week 2,229 (20.3) 162 (15.1) 616 (19.7) 870 (21.8) 496 (21.6) 73 (18.2) 12 (12.6)  
≥7 drinks per week 900 (8.2) 58 (5.4) 235 (7.5) 339 (8.5) 222 (9.7) 39 (9.7) 7 (7.4)  
Smoking status (n=10,937)         
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Table 1. Characteristics in WHI BMD cohort by hours of sleeping per night. N (%) or Mean (SD). 
  Self-reported usual sleep duration 
 Total ≤5 hours 6 7 8 9 ≥10 hours p-value 
 11,084 1,080 3,157 4,025 2,320 405 97  
Never  5,948 (54.4) 602 (56.3) 1,710 (55.0) 2,158 (54.2) 1,232 (53.9) 204 (51.4) 42 (44.2) <0.001 
Former  4,100 (37.5) 369 (34.5) 1,112 (35.8) 1,524 (38.3) 898 (39.3) 159 (40.1) 38 (40.0)  
Current  889 (8.1) 98 (9.2) 288 (9.3) 298 (7.5) 156 (6.8) 34 (8.6) 15 (15.8)  
Age at menopause         
Mean (SD) 47.5 (6.9) 46.1 (7.5) 47.5 (7.0) 47.7 (6.8) 47.7 (6.6) 48.0 (6.6) 47.3 (6.8) <0.001 
Missing 1,124 116 309 399 245 44 11  
HT use (n=1079)         
Never used 5,257 (47.5) 566 (52.4) 1,518 (48.1) 1,838 (45.7) 1,097 (47.3) 182 (44.9) 56 (57.7) <0.001 
Past user 1,762 (15.9) 189 (17.5) 490 (15.5) 656 (16.3) 343 (14.8) 68 (16.8) 16 (16.5)  
Current user 4,060 (36.6) 325 (30.1) 1,145 (36.3) 1,531 (38.0) 879 (37.9) 155 (38.3) 25 (25.8)  
Hot flash or night sweats in 
past 4 weeks 
        
No/Mild 9,787 (88.8) 827 (77.3) 2,776 (88.4) 3,652 (91.3) 2,104 (91.0) 354 (88.7) 74 (77.1) <0.001 
Moderate/Severe 1,231 (11.2) 243 (22.7) 365 (11.6) 349 (8.7) 207 (9.0) 45 (11.3) 22 (22.9)  
Missing 66 10 16 24 9 6 1  
Diet and supplemental 
calcium intake 
1113 (719) 1018 (682) 1073 (717) 1147 (714) 1158 (742) 1122 (728) 945 (669) <0.001 
   Missing 28 1 6 9 11 1 0  
Diet and supplemental 
vitamin D intake 
8.1 (6.6) 7.3 (6.2) 7.9 (6.7) 8.4 (6.5) 8.4 (6.9) 8.3 (6.6) 6.9 (6.4) <0.001 
   Missing 29 1 6 10 11 1 0  
Hypnotics 

















   Yes 121 (1.1) 28 (2.6) 31 (1.0) 37 (0.9) 17 (0.7) 5 (1.2) 3 (3.1)  
WHI Insomnia rating score         
0-3 2,956 (26.7) 102 (9.4) 628 (19.9) 1,194 (29.7) 852 (36.7) 153 (37.8) 27 (27.8) <0.001 
4-6 2,927 (26.4) 106 (9.8) 700 (22.2) 1,197 (29.7) 762 (32.8) 136 (33.6) 26 (26.8)  
7-10 2,849 (25.7) 217 (20.1) 885 (28.0) 1,115 (27.7) 526 (22.7) 84 (20.7) 22 (22.7)  
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Table 1. Characteristics in WHI BMD cohort by hours of sleeping per night. N (%) or Mean (SD). 
  Self-reported usual sleep duration 
 Total ≤5 hours 6 7 8 9 ≥10 hours p-value 
 11,084 1,080 3,157 4,025 2,320 405 97  
≥11 2,352 (21.2) 655 (60.6) 944 (29.9) 519 (12.9) 180 (7.8) 32 (7.9) 22 (22.7)  
Insomnia rating score cutoff         
<9 7,457 (67.3) 303 (28.1) 1,790 (56.7) 3,019 (75.0) 1,942 (83.7) 342 (84.4) 61 (62.9) <0.001 
≥9 3,627 (32.7) 777 (71.9) 1,367 (43.3) 1,006 (25.0) 378 (16.3) 63 (15.6) 36 (37.1)  
Total hip BMD (g/cm2)         












Femoral neck BMD (g/cm2)         












AP spine BMD (g/cm2)         












Whole body BMD (g/cm2)         












P-value is ANOVA or chi-square. 
This article is protected by copyright. All rights reserved.
24 
 
Table 2. Linear regression models for bone mineral density (g/cm2) and 
usual sleep duration. 
  Model 1 Model 2 
 N Beta (95% CI) Beta (95% CI) 
Total Hip BMD 
≤5 hours 1080 -0.007 (-0.016, 0.001) -0.015 (-0.024, -0.006) 
6 hours 3157 0.001 (-0.005, 0.007) -0.002 (-0.008, 0.004) 
7 hours 4025 Reference Reference 
8 hours 2320 0.0001 (-0.006, 0.006) -0.002 (-0.008, 0.005) 
9 hours 405 0.005 (-0.008, 0.018) -0.002 (-0.015, 0.011) 
≥10 hours 97 0.008 (-0.018, 0.033) -0.007 (-0.034, 0.020) 
Overall F-test  0.428 0.033 
Femoral Neck BMD 
≤5 hours 1080 -0.004 (-0.011, 0.004)  -0.012 (-0.019, -0.004) 
6 hours 3157 0.001 (-0.005, 0.006) -0.002 (-0.007, 0.003) 
7 hours 4025 Reference Reference 
8 hours 2320 0.001 (-0.005, 0.006) -0.001 (-0.007, 0.005) 
9 hours 405 0.010 (-0.001, 0.022) 0.001 (-0.011, 0.013) 
≥10 hours 97 0.008 (-0.015, 0.030) -0.008 (-0.032, 0.016) 
Overall F-test  0.421 0.078 
Spine BMD 
≤5 hours 1080 -0.010 (-0.021, 0.002) -0.018 (-0.029, -0.006) 
6 hours 3157 -0.005 (-0.012, 0.003) -0.008 (-0.016, -0.001) 
7 hours 4025 Reference Reference 
8 hours 2320 0.000 (-0.008, 0.009) -0.001 (-0.010, 0.008) 
9 hours 405 0.014 (-0.003, 0.031) 0.006 (-0.012, 0.023) 
≥10 hours 97 -0.007 (-0.041, 0.026) -0.031 (-0.068, 0.005) 
Overall F-test  0.156 0.010 
Whole Body BMD 
≤5 hours 1080 -0.015 (-0.021, -0.008) -0.018 (-0.025, -0.011) 
6 hours 3157 -0.004 (-0.008, 0.001) -0.005 (-0.010, -0.0001) 
7 hours 4025 Reference Reference 
8 hours 2320 -0.000 (-0.005, 0.005) -0.001 (-0.006, 0.005) 
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Table 2. Linear regression models for bone mineral density (g/cm2) and 
usual sleep duration. 
  Model 1 Model 2 
 N Beta (95% CI) Beta (95% CI) 
9 hours 405 0.002 (-0.008, 0.012) -0.005 (-0.015, 0.006) 
≥10 hours 97 -0.013 (-0.033, 0.007) -0.022 (-0.044, 0.001) 
Overall F-test  <0.001 <0.001 
Model 1 – adjusted for DXA serial number, age, menopausal symptoms and race.  
Model 2 – adjusted for Model 1 plus education, smoking, physical activity, BMI, alcohol 
use, physical function score, and sleep medication use. 




Table 3. Multinomial logistic regression of sleep duration and odds of low bone mass or osteoporosis compared to normal 
bone mass. 
 
Low Bone Mass vs Normal  Osteoporosis vs Normal  
p-value* N Model 1†  
OR (95% CI) 
Model 2‡ 
OR (95% CI) 
N Model 1†   
OR (95% CI) 
Model 2‡  
OR (95% CI) 
Total Hip        
≤5 hours 419 1.07 (0.92, 1.25) 1.22 (1.03, 1.45) 67 1.45 (1.07, 1.97) 1.63 (1.15, 2.31)  
 
0.135 
6 hours 1239 1.01 (0.91, 1.11) 1.01 (0.90, 1.14) 161 1.04 (0.84, 1.31) 1.10 (0.86, 1.42) 
7 hours 1595 Reference Reference 207 Reference Reference 
8 hours 947 1.03 (0.92, 1.14) 1.02 (0.90, 1.15) 111 0.94 (0.73, 1.20) 0.99 (0.74, 1.31) 
9+ hours 188 0.92 (0.75, 1.13) 1.03 (0.81, 1.30) 30 1.17 (0.76, 1.78) 1.45 (0.91, 2.32) 
Femoral Neck 
≤5 hours 534 0.97 (0.84, 1.13) 1.07 (0.90, 1.27) 111 1.12 (0.87, 1.44) 1.30 (0.97, 1.74)  
 
0.657 
6 hours 1584 0.94 (0.85, 1.04) 0.97 (0.86, 1.09) 326 1.01 (0.85, 1.20) 1.11 (0.91, 1.35) 
7 hours 2100 Reference Reference 415 Reference Reference 
8 hours 1202 0.96 (0.86, 1.08) 0.96 (0.85, 1.09) 243 0.99 (0.82, 1.20) 1.05 (0.84, 1.30) 
9+ hours 259 0.95 (0.77, 1.16) 1.11 (0.87, 1.41) 45 0.82 (0.57, 1.18) 1.11 (0.74, 1.68) 
Spine        
≤5 hours 416 1.07 (0.92, 1.24) 1.07 (0.90, 1.26) 186 1.13 (0.93, 1.38) 1.28 (1.02, 1.60)  
 
0.264 
6 hours 1193 1.04 (0.94, 1.15) 1.06 (0.94, 1.19) 537 1.13 (0.99, 1.30) 1.17 (1.00, 1.37) 
7 hours 1513 Reference Reference 610 Reference Reference 
8 hours 833 0.94 (0.84, 1.05) 0.94 (0.83, 1.07) 373 1.03 (0.89, 1.20) 1.08 (0.91, 1.28) 
9+ hours 180 0.87 (0.71, 1.07) 0.91 (0.73, 1.15) 71 0.81 (0.60, 1.08) 1.03 (0.75, 1.41) 
Whole Body 
≤5 hours 466 1.31 (1.13, 1.52) 1.37 (1.17, 1.62) 82 1.82 (1.37, 2.43) 1.94 (1.42, 2.67)  
 
<0.001 
6 hours 1310 1.08 (0.97, 1.19) 1.08 (0.96, 1.20) 195 1.22 (0.99, 1.50) 1.27 (1.00, 1.60) 
7 hours 1657 Reference Reference 224 Reference Reference 
8 hours 927 0.96 (0.86, 1.08) 0.95 (0.85, 1.08) 160 1.25 (1.00, 1.56) 1.27 (0.99, 1.63) 
9+ hours 185 0.88 (0.72, 1.08) 0.97 (0.78, 1.22) 34 1.18 (0.79, 1.77) 1.29 (0.82, 2.03) 
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Table 3. Multinomial logistic regression of sleep duration and odds of low bone mass or osteoporosis compared to normal 
bone mass. 
 
Low Bone Mass vs Normal  Osteoporosis vs Normal  
p-value* N Model 1†  
OR (95% CI) 
Model 2‡ 
OR (95% CI) 
N Model 1†   
OR (95% CI) 
Model 2‡  
OR (95% CI) 
*P-value is overall type 3 Wald test for multinomial logistic Model 2. 
†Model 1 adjusted for DXA serial number, age, menopausal symptoms and race. 
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